The safety of ixekizumab in psoriasis drug therapy

Puig, L

Puig, L (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Dermatol, Mas Casanovas 90, Barcelona 08041, Catalonia, Spain.

EXPERT OPINION ON DRUG SAFETY, 2020; 19 (2): 117

Abstract

Introduction: Ixekizumab, a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A, has been approved by the Uni......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索